Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis-Reference-Cited by-同舟云学术

Blood-based diagnosis of Alzheimer's disease using fingerprinting metabolomics based on hydrophilic interaction liquid chromatography with mass spectrometry and multivariate statistical analysis

Published:2015-01 Issue: Volume:974 Page:24-34
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Inoue Koichi,Tsuchiya Hirofumi,Takayama Takahiro,Akatsu Hiroyasu,Hashizume Yoshio,Yamamoto Takayuki,Matsukawa Noriyuki,Toyo’oka Toshimasa

Funder

Japanese Brain Bank Network for Neuroscience Research

Ministry of Education, Culture, Sports, Science, and Technology of Japan

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference27 articles.

1. The Application of Cerebrospinal Fluid Biomarkers in Early Diagnosis of Alzheimer Disease

2. Alzheimer’s Disease Dementia Guidelines for Diagnostic Testing

3. Developing novel blood‐based biomarkers for Alzheimer's disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profile of key metabolites and identification of HMGCS1-DHEA pathway in porcine Sertoli cells treated by Vitamin C;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. The omics technologies and liquid biopsies: Advantages, limitations, applications;Medicine in Omics;2024-08

3. Untargeted metabolomic profiling identifies Alzheimer’s disease-specific signatures in serum and faeces impacted by tetrahydroxy stilbene glycoside through UPLC-Q-TOF/MS;Pharmacological Research - Modern Chinese Medicine;2024-03

4. Small molecule metabolites: discovery of biomarkers and therapeutic targets;Signal Transduction and Targeted Therapy;2023-03-20

5. The associations of serum valine with mild cognitive impairment and Alzheimer’s disease;Aging Clinical and Experimental Research;2022-04-01